D
Design Therapeutics, Inc. DSGN
$5.41 $0.214.04% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -25.65% 4.22% 25.84% 33.97% 31.97%
Total Depreciation and Amortization 7.73% 11.07% 10.99% 11.85% 15.18%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 72.63% 27.39% -2.23% -31.07% -39.43%
Change in Net Operating Assets 138.61% 114.10% -236.40% -273.15% -254.34%
Cash from Operations 0.77% 11.42% 26.39% 24.34% 15.26%
Capital Expenditure 67.20% 40.38% -32.81% 29.01% 43.67%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -65.13% -41.57% -16.10% 3.45% 316.57%
Cash from Investing -65.11% -41.58% -16.33% 3.82% 310.11%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -15.07% -30.65% -29.14% 112.75% 55.40%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -15.07% -30.65% -29.14% 112.75% 55.40%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -240.50% -2,775.17% 125.72% 116.37% 120.01%